Related Experiment Video
Updated: Apr 29, 2026

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
Published on: April 2, 2020
Tumor-derived extracellular mutations of PTPRT /PTPrho are defective in cell adhesion
Jianshi Yu1, Scott Becka, Peng Zhang
1Department of Genetics and Case Comprehensive Cancer Center, Case Western Reserve University, Euclid Avenue, Cleveland, OH 44106, USA.
Abstract:
Receptor protein tyrosine phosphatase T (PTPRT/PTPrho) is frequently mutated in human cancers including colon, lung, gastric, and skin cancers. More than half of the identified tumor-derived mutations are located in the extracellular part of PTPrho. However, the functional significance of those extracellular domain mutations remains to be defined. Here we report that the extracellular domain of PTPrho mediates homophilic cell-cell aggregation. This homophilic interaction is very specific because PTPrho does not interact with its closest homologue, PTPmu, in a cell aggregation assay. We further showed that all five tumor-derived mutations located in the NH(2)-terminal MAM and immunoglobulin domains impair, to varying extents, their ability to form cell aggregates, indicating that those mutations are loss-of-function mutations. Our results suggest that PTPrho may play an important role in cell-cell adhesion and that mutational inactivation of this phosphatase could promote tumor migration and metastasis.
Insights
Receptor protein tyrosine phosphatase T (PTPRT/PTPrho) mutations in cancer impair its cell-cell adhesion function. Loss of this function may drive tumor migration and metastasis.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Receptor protein tyrosine phosphatase T (PTPRT/PTPrho) is frequently mutated in various human cancers.
- Over half of these mutations occur in the extracellular domain, but their functional impact is unknown.
Purpose of the Study:
- To investigate the function of the extracellular domain of PTPRT/PTPrho.
- To determine the impact of tumor-derived mutations on PTPRT/PTPrho function.
Main Methods:
- Cell aggregation assays were used to assess homophilic interaction of PTPRT/PTPrho.
- Specific interactions with PTPmu were tested.
- The effect of tumor-derived mutations on cell aggregation was evaluated.
Main Results:
- The extracellular domain of PTPRT/PTPrho mediates specific homophilic cell-cell aggregation.
- PTPRT/PTPrho does not interact with its homolog PTPmu.
- Five tumor-derived mutations in the extracellular domains resulted in impaired cell aggregation, indicating loss-of-function.
Conclusions:
- PTPRT/PTPrho plays a role in cell-cell adhesion.
- Mutational inactivation of PTPRT/PTPrho may contribute to tumor progression, including migration and metastasis.
More Related Videos
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
04:56Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Related Concept Videos
Abnormal Proliferation
The Ras Gene
Ras is a...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Intracellular Signaling Affects Focal Adhesions
Some...